Publication:
Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes

Simple item page
dc.contributor.authorJack Wei Chieh Tanen_US
dc.contributor.authorDavid Simen_US
dc.contributor.authorJunya Akoen_US
dc.contributor.authorWael Almahmeeden_US
dc.contributor.authorMark E. Cooperen_US
dc.contributor.authorJamshed J. Dalalen_US
dc.contributor.authorChaicharn Deerochanawongen_US
dc.contributor.authorDavid Wei Chun Huangen_US
dc.contributor.authorSofian Joharen_US
dc.contributor.authorUpendra Kaulen_US
dc.contributor.authorSin Gon Kimen_US
dc.contributor.authorNatalie Kohen_US
dc.contributor.authorAlice Pik Shan Kongen_US
dc.contributor.authorRungroj Krittayaphongen_US
dc.contributor.authorBernard Kwoken_US
dc.contributor.authorBien J. Matawaranen_US
dc.contributor.authorQuang Ngoc Nguyenen_US
dc.contributor.authorLoke Meng Ongen_US
dc.contributor.authorJin Joo Parken_US
dc.contributor.authorYongde Pengen_US
dc.contributor.authorDavid K.L. Queken_US
dc.contributor.authorKetut Suastikaen_US
dc.contributor.authorNorlela Sukoren_US
dc.contributor.authorBoon Wee Teoen_US
dc.contributor.authorChee Kiang Teohen_US
dc.contributor.authorJian Zhangen_US
dc.contributor.authorEugenio B. Reyesen_US
dc.contributor.authorSu Yen Gohen_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherChinese Academy of Medical Sciences & Peking Union Medical Collegeen_US
dc.contributor.otherCleveland Clinic Abu Dhabien_US
dc.contributor.otherHospital Pulau Pinangen_US
dc.contributor.otherSeoul National University Bundang Hospitalen_US
dc.contributor.otherRaja Isteri Pengiran Anak Saleha Hospitalen_US
dc.contributor.otherUniversity of the Philippines Manilaen_US
dc.contributor.otherUniversity of Santo Tomas, Manilaen_US
dc.contributor.otherHanoi Medical Universityen_US
dc.contributor.otherNational Yang-Ming University Taiwanen_US
dc.contributor.otherUniversitas Udayanaen_US
dc.contributor.otherBatra Hospital Indiaen_US
dc.contributor.otherKorea University College of Medicineen_US
dc.contributor.otherHospital Canselor Tuanku Muhriz UKMen_US
dc.contributor.otherNUS Yong Loo Lin School of Medicineen_US
dc.contributor.otherShanghai Jiao Tong Universityen_US
dc.contributor.otherVeterans General Hospital-Kaohsiung Taiwanen_US
dc.contributor.otherInstitut Jantung Negara Kuala Lumpuren_US
dc.contributor.otherMonash Universityen_US
dc.contributor.otherSingapore General Hospitalen_US
dc.contributor.otherPantai Holdings Sdn Bhden_US
dc.contributor.otherKitasato Universityen_US
dc.contributor.otherRajavithi Hospitalen_US
dc.contributor.otherNational Heart Centre, Singaporeen_US
dc.contributor.otherFooyin University Taiwanen_US
dc.contributor.otherChinese University of Hong Kongen_US
dc.contributor.otherSengkang General Hospitalen_US
dc.contributor.otherFarrer Park Hospitalen_US
dc.contributor.otherKokilaben Hospitalen_US
dc.date.accessioned2022-08-04T11:09:43Z
dc.date.available2022-08-04T11:09:43Z
dc.date.issued2021-01-01en_US
dc.description.abstractThe Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.en_US
dc.identifier.citationEuropean Cardiology Review. Vol.16, (2021)en_US
dc.identifier.doi10.15420/ECR.2020.52en_US
dc.identifier.issn17583764en_US
dc.identifier.issn17583756en_US
dc.identifier.other2-s2.0-85105579149en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/78747
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105579149&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleConsensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105579149&origin=inwarden_US

Files

Collections

Scopus 2021